Fibrosis pulmonar como secuela pulmonar parenquimatosa provocada por covid 19: una revisión bibliográfica

Abstract

Introduction: Pulmonary fibrosis is an interstitial lung disease characterized by lack of normal healing, causing difficulty breathing due to lack of oxygen intake. The progress to developing fibrosis depends on several factors such as habits, patient comorbidities and diseases such as pneumonia and respiratory distress syndrome. Objective: To carry out a review of effective information on pulmonary fibrosis as a sequel to Covid-19, which allows health sciences personnel to obtain new knowledge about this common disease today. Materials and methods: An exhaustive search for information on pulmonary fibrosis as a consequence of Covid-19 was carried out through databases such as: Springer, Google Scholar, PMC, NCBI, where articles from the last 2 years were collected in English and Spanish. . Results and discussion: After an exhaustive search for information, it was obtained that fibrosis develops mainly due to lung injury due to severe effects of the coronavirus, as well as the lack of effective therapies to stop the progression of fibrosis. The main diagnostic methods were identified, with chest tomography being the gold standard to identify this disease. Antifibrotic therapies currently help the progression and worsening of lung function. Conclusion: It is concluded that the work carried out shows that patients who did not fully recover from the covid-19 infection and who during their hospital stay suffered severe deterioration developed pulmonary fibrosis